Related references
Note: Only part of the references are listed.The Natural Viral Load Profile of Patients With Pandemic 2009 Influenza A(H1N1) and the Effect of Oseltamivir Treatment
Iris W. Li et al.
CHEST (2010)
Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection
Kelvin K. W. To et al.
CLINICAL INFECTIOUS DISEASES (2010)
Rapid Selection of Oseltamivir- and Peramivir-Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts
Matthew J. Memoli et al.
CLINICAL INFECTIOUS DISEASES (2010)
Intravenous Zanamivir for Patients with Pneumonitis due to Pandemic (H1N1) 2009 Influenza Virus
Georg Haerter et al.
CLINICAL INFECTIOUS DISEASES (2010)
Effect of Clinical and Virological Parameters on the Level of Neutralizing Antibody against Pandemic Influenza A Virus H1N1 2009
Ivan F. N. Hung et al.
CLINICAL INFECTIOUS DISEASES (2010)
The Infection Attack Rate and Severity of 2009 Pandemic H1N1 Influenza in Hong Kong
Joseph T. Wu et al.
CLINICAL INFECTIOUS DISEASES (2010)
Hark back: Passive immunotherapy for influenza and other serious infections
Thomas C. Luke et al.
CRITICAL CARE MEDICINE (2010)
Differences in the Epidemiological Characteristics and Clinical Outcomes of Pandemic (H1N1) 2009 Influenza, Compared with Seasonal Influenza
Kevin T. Shiley et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Viral Load in Patients Infected With Pandemic H1N1 2009 Influenza A Virus
Kelvin K. W. To et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
Neutralization of Human Respiratory Syncytial Virus Infectivity by Antibodies and Low-Molecular-Weight Compounds Targeted against the Fusion Glycoprotein
Margarita Magro et al.
JOURNAL OF VIROLOGY (2010)
Identification of influenza A nucleoprotein as an antiviral target
Richard Y. Kao et al.
NATURE BIOTECHNOLOGY (2010)
Concurrent comparison of epidemiology, clinical presentation and outcome between adult patients suffering from the pandemic influenza A (H1N1) 2009 virus and the seasonal influenza A virus infection
Kelvin K. W. To et al.
POSTGRADUATE MEDICAL JOURNAL (2010)
Logistical feasibility and potential benefits of a population-wide passive-immunotherapy program during an influenza pandemic
Joseph T. Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Practical limitations of convalescent plasma collection: a case scenario in pandemic preparation for influenza A (H1N1) infection
Hoi K. Wong et al.
TRANSFUSION (2010)
Long-term immunogenicity of influenza vaccine among the elderly: Risk factors for poor immune response and persistence
Joon Young Song et al.
VACCINE (2010)
Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome
Andrew Davies et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California
Janice K. Louie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Confirmation of the First Hong Kong Case of Human Infection by Novel Swine Origin Influenza A (H1N1) Virus Diagnosed Using Ultrarapid, Real-Time Reverse Transcriptase PCR
Susanna K. P. Lau et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis
Santiago Echevarria-Zuno et al.
LANCET (2009)
The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza
Debra Birnkrant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China
Bin Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Critical Care Services and 2009 H1N1 Influenza in Australia and New Zealand.
Steven A. R. Webb et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.
Seema Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus.
Kathy Hancock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Oseltamivir-Resistant Influenza A Pandemic (H1N1) 2009 Virus, Hong Kong, China
Honglin Chen et al.
EMERGING INFECTIOUS DISEASES (2009)
Treatment of Argentine hemorrhagic fever
Delia A. Enria et al.
ANTIVIRAL RESEARCH (2008)
Treatment with convalescent plasma for influenza A (H5N1) infection
Boping Zhou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza
Cameron P. Simmons et al.
PLOS MEDICINE (2007)
Meta-analysis: Convalescent blood products for Spanish influenza pneumonia: A future H5N1 treatment?
Thomas C. Luke et al.
ANNALS OF INTERNAL MEDICINE (2006)
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice
Brendon J. Hanson et al.
RESPIRATORY RESEARCH (2006)
Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital
KM Yeh et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Acute renal impairment in coronavirus-associated severe acute respiratory syndrome
KH Chu et al.
KIDNEY INTERNATIONAL (2005)
Share Paper
